Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

5 treatments under study, led by Zweymüller

Related Conditions

Often studied with 12 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

33.3%

1 terminated out of 3 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Recruiting1
Terminated1
Completed1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT05734651Recruiting

PROMIS Evaluation Study

NCT00958464CompletedPrimary

The Effect of Perthes' Disease on Hip Cartilage

NCT00208468Phase 3Terminated

A Randomised Multi-centre Study to Compare the Long-term Performance of the Future Hip to 3 Other Implants in Primary Total Hip Replacement

Showing all 3 trials

Research Network

Common Treatments

  • Zweymüller1
  • Mri1
  • Cls Spotorno1
  • European Hip1
  • Promis Stem1

Active Sponsors

  • Tyrolean Arthroplasty Registry1
  • University of British Columbia1
  • DePuy International1
  • Bezirkskrankenhaus St. Johann in Tirol1

Top Investigators

Related Conditions

  • Slipped Capital Femoral Epiphysis1
  • Femoral Neck Fractures1
  • Collagen Disorders1
  • Osteonecrosis1
  • Hip Arthropathy1

Activity Timeline